Kang Dae Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kang Dae Lee has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Jong Chul Hong
Department of Otolaryngology-Head and Neck Surgery, Dong-A University College of Medicine, Busan, Korea
4 shared publicationsSung Won Kim
Department of Otolaryngology–Head and Neck Surgery Kosin University College of Medicine, Busan Korea
4 shared publicationsHyoung Shin Lee
Department of Otolaryngology-Head and Neck Surgery, Kosin University College of Medicine, Busan, Korea
3 shared publicationsDae Hyoung Kang
Department of Otolaryngology-Head and Neck Surgery, Kosin University College of Medicine, Busan, Korea
2 shared publicationsHyo Sang Park
Kosin University College of Medicine
2 shared publicationsSeung Tae Kim
Department of Otolaryngology–Head and Neck Surgery Kosin University College of Medicine, Busan Korea
2 shared publications
Latest Publications
- Open Access
- 30 June 2013
- Published by The Korean Society for Laser Medicine and Surgery in Medical Lasers
- Vol. 2 (1) , 1-7
Transoral Laser Surgery for Supraglottic Carcinoma
Primary treatment modalities of supraglottic cancer usually consist of single or combined methods. Treatment protocols include single transoral surgery, external transcervical approach, and radiation therapy or a combination of these methods. The objective of surgery for supraglottic cancer is cure of the tumor, with preservation of voice, deglutition, and an intact airway. Transoral laser surgery is found to achieve comparable oncologic results with open surgery. Moreover, the complication rate was lower in laser surgery compared to the conventional open approaches and there were no major complications. Transoral laser supraglottic laryngectomy seems to be a feasible and oncologically safe procedure in the treatment of fresh or recurrent supraglottic cancer ranging from T1 to selected T3 with minimal preepiglottic space involvement.
- 30 June 2013
- Published by The Korean Society for Laser Medicine and Surgery in Medical Lasers
- Vol. 2 (1) , 1-7
Open AccessTransoral Laser Surgery for Supraglottic Carcinoma
Primary treatment modalities of supraglottic cancer usually consist of single or combined methods. Treatment protocols include single transoral surgery, external transcervical approach, and radiation therapy or a combination of these methods. The objective of surgery for supraglottic cancer is cure of the tumor, with preservation of voice, deglutition, and an intact airway. Transoral laser surgery is found to achieve comparable oncologic results with open surgery. Moreover, the complication rate was lower in laser surgery compared to the conventional open approaches and there were no major complications. Transoral laser supraglottic laryngectomy seems to be a feasible and oncologically safe procedure in the treatment of fresh or recurrent supraglottic cancer ranging from T1 to selected T3 with minimal preepiglottic space involvement.
- 1 April 2013
- Published by Wiley in The Laryngoscope
- Vol. 123 (11) , 2670-2674
Transoral laser microsurgery for early glottic cancer as one‐stage single‐modality therapy
Objectives/Hypothesis: A study was undertaken to determine the oncologic outcomes in a consecutive series of early glottic carcinomas treated with transoral CO2 laser microsurgery (TLM) as a one‐stage single‐modality therapy, without any postoperative radiation therapy or retreatment with laser. We further evaluated correlations between the oncologic outcomes and clinicopathologic factors including tumor location and surgical margin.Study Design: Retrospective analysis of medical records.Methods: The medical records of 118 consecutive patients with early stage (T1, T2) glottic carcinoma who underwent TLM by a single surgeon as an initial treatment from 1997 to 2011 were retrospectively reviewed. The oncologic outcomes were evaluated, and correlations to clinicopathologic factors were analyzed.Results: The 5‐year disease‐free survival, ultimate local control with laser alone, disease‐specific survival, overall survival, and organ preservation rates were 87.9%, 94.2%, 99.0%, 92.2%, and 96.2%, respectively. Neither the reported surgical margin nor the extension of tumor to the anterior commissure, arytenoid, subglottis, and ventricle showed any significant impact on local control or survival.Conclusions: Transoral CO2 laser microsurgery as one‐stage single‐modality therapy resulted in a high rate of local control and a high survival rate in selected cases of early glottic carcinoma, regardless of the location of tumor and histopathology report on the surgical margin.Level of Evidence: 4 Laryngoscope, 123:2670–2674, 2013
- 1 April 2013
- Published by Wiley in The Laryngoscope
- Vol. 123 (11) , 2670-2674
Transoral laser microsurgery for early glottic cancer as one‐stage single‐modality therapy
Objectives/Hypothesis: A study was undertaken to determine the oncologic outcomes in a consecutive series of early glottic carcinomas treated with transoral CO2 laser microsurgery (TLM) as a one‐stage single‐modality therapy, without any postoperative radiation therapy or retreatment with laser. We further evaluated correlations between the oncologic outcomes and clinicopathologic factors including tumor location and surgical margin.Study Design: Retrospective analysis of medical records.Methods: The medical records of 118 consecutive patients with early stage (T1, T2) glottic carcinoma who underwent TLM by a single surgeon as an initial treatment from 1997 to 2011 were retrospectively reviewed. The oncologic outcomes were evaluated, and correlations to clinicopathologic factors were analyzed.Results: The 5‐year disease‐free survival, ultimate local control with laser alone, disease‐specific survival, overall survival, and organ preservation rates were 87.9%, 94.2%, 99.0%, 92.2%, and 96.2%, respectively. Neither the reported surgical margin nor the extension of tumor to the anterior commissure, arytenoid, subglottis, and ventricle showed any significant impact on local control or survival.Conclusions: Transoral CO2 laser microsurgery as one‐stage single‐modality therapy resulted in a high rate of local control and a high survival rate in selected cases of early glottic carcinoma, regardless of the location of tumor and histopathology report on the surgical margin.Level of Evidence: 4 Laryngoscope, 123:2670–2674, 2013
- 25 February 2012
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 64 (2) , 120-130
Voice Examination in Patients with Decreased High Pitch after Thyroidectomy
Decreased high pitch after thyroidectomy due to injury of the external branch of superior laryngeal nerve (EBSLN) may be a critical, especially to professional voice users. The author studied the usefulness of VRP (voice range profile) and MDVP (multi-dimensional voice program) to evaluate patients who have decreased high pitch after thyroidectomy. A study was performed with 58 females and 9 males who underwent voice assessment between January 2008 and June 2009. The patients were classified as the group of female with no decreased high pitch (group A, n = 52), decreased high pitch (group B, n = 6) and the group of male with no decreased high pitch (group C, n = 9). VRP and laryngeal electromyogram (EMG) was performed in group B. Results: The preoperative frequency range of group A and B were statistically not different. In Group B, the result of VRP showed that the frequency range was 443.11 ± 83.97, 246.67 ± 49.41, 181.37 ± 80.13 Hz showing significant decrease after the surgery compared to that of the preoperative result. (P < 0.05) In addition, the intensity range was 22.25 ± 2.87, 15.25 ± 2.22, 16.25 ± 2.63 dB respectively showing significant postoperative decrease. (P < 0.05) EMG of the cricothyroid muscle of group B showed decreased potential with 3 patients, normal potential in 2, and the other patient refused to take the examination. In group A and C, the result of VRP revealed no significant difference between the preoperative and postoperative result. VRP is a noninvasive, quick, and practical test to demonstrate decreased frequency range visually and helps to evaluate EBSLN injury in patient with thyroidectomy.
- 25 February 2012
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 64 (2) , 120-130
Voice Examination in Patients with Decreased High Pitch after Thyroidectomy
Decreased high pitch after thyroidectomy due to injury of the external branch of superior laryngeal nerve (EBSLN) may be a critical, especially to professional voice users. The author studied the usefulness of VRP (voice range profile) and MDVP (multi-dimensional voice program) to evaluate patients who have decreased high pitch after thyroidectomy. A study was performed with 58 females and 9 males who underwent voice assessment between January 2008 and June 2009. The patients were classified as the group of female with no decreased high pitch (group A, n = 52), decreased high pitch (group B, n = 6) and the group of male with no decreased high pitch (group C, n = 9). VRP and laryngeal electromyogram (EMG) was performed in group B. Results: The preoperative frequency range of group A and B were statistically not different. In Group B, the result of VRP showed that the frequency range was 443.11 ± 83.97, 246.67 ± 49.41, 181.37 ± 80.13 Hz showing significant decrease after the surgery compared to that of the preoperative result. (P < 0.05) In addition, the intensity range was 22.25 ± 2.87, 15.25 ± 2.22, 16.25 ± 2.63 dB respectively showing significant postoperative decrease. (P < 0.05) EMG of the cricothyroid muscle of group B showed decreased potential with 3 patients, normal potential in 2, and the other patient refused to take the examination. In group A and C, the result of VRP revealed no significant difference between the preoperative and postoperative result. VRP is a noninvasive, quick, and practical test to demonstrate decreased frequency range visually and helps to evaluate EBSLN injury in patient with thyroidectomy.
- 1 January 2012
- Published by Korean Society of Otorhinolaryngology-Head and Neck Surgery in Korean Journal of Otorhinolaryngology-Head and Neck Surgery
- Vol. 55 (3) , 166-172
The Treatment Outcomes of Medullary Thyroid Carcinoma
- 1 January 2012
- Published by Korean Society of Otorhinolaryngology-Head and Neck Surgery in Korean Journal of Otorhinolaryngology-Head and Neck Surgery
- Vol. 55 (3) , 166-172
The Treatment Outcomes of Medullary Thyroid Carcinoma
- Open Access
- 1 January 2011
- Published by Korean Association of Thyroid and Endocrine Surgeons in Korean Journal of Endocrine Surgery
- Vol. 11 (3) , 175-178
Voice-related Outcome after Thyroidectomy
Hong JC, et al. Korean J Endocr Surg. 2011 Sep;11(3):175-178. https://doi.org/10.16956/kjes.2011.11.3.175
- 1 January 2011
- Published by Korean Association of Thyroid and Endocrine Surgeons in Korean Journal of Endocrine Surgery
- Vol. 11 (3) , 175-178
Open AccessVoice-related Outcome after Thyroidectomy
Hong JC, et al. Korean J Endocr Surg. 2011 Sep;11(3):175-178. https://doi.org/10.16956/kjes.2011.11.3.175
- 1 January 2011
- Published by Korean Society of Otorhinolaryngology-Head and Neck Surgery in Korean Journal of Otorhinolaryngology-Head and Neck Surgery
- Vol. 54 (8) , 567-569
A Case of Surgical Treatment for Sialolithiasis in Stensen's Duct Using Ultrasonography
- 1 January 2011
- Published by Korean Society of Otorhinolaryngology-Head and Neck Surgery in Korean Journal of Otorhinolaryngology-Head and Neck Surgery
- Vol. 54 (8) , 567-569
A Case of Surgical Treatment for Sialolithiasis in Stensen's Duct Using Ultrasonography